Search

Your search keyword '"Jiang, Yongfang"' showing total 215 results

Search Constraints

Start Over You searched for: Author "Jiang, Yongfang" Remove constraint Author: "Jiang, Yongfang"
215 results on '"Jiang, Yongfang"'

Search Results

5. Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

6. Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China

8. Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures

9. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

15. The value of metagenomic next-generation sequencing with blood samples for the diagnosis of disseminated tuberculosis.

17. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma

18. FRI-088 Patterns and predictors of postacute discharge location other than home in a global cohort of 3, 678 patients hospitalized with cirrhosis

22. Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks

25. Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

31. Novel, high accuracy prediction models of hepatocellular carcinoma based on longitudinal data and cell-free DNA signatures

32. Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED study

33. Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China

34. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

35. OS-033 - Novel, high accuracy prediction models of hepatocellular carcinoma based on longitudinal data and cell-free DNA signatures

38. High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy

40. Competitive evolved sub‐clonal BCR::ABL1 and novel MSI2:: PC fusion genes in myelodysplastic syndrome with isolated del(5q)

41. Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update

42. Additional file 1 of Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma

43. Additional file 3 of Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma

44. Additional file 2 of Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma

46. hMSCs-derived exosome circCDK13 inhibits liver fibrosis by regulating the expression of MFGE8 through miR-17-5p/KAT2B.

47. Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection – an open‐label, phase 2 study

50. Competitive evolved sub‐clonal BCR::ABL1 and novel MSI2::PC fusion genes in myelodysplastic syndrome with isolated del(5q).

Catalog

Books, media, physical & digital resources